EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Noninvasive monitoring with bowel ultrasound (NIMBUS) in paediatric inflammatory bowel disease: Feasibility in a single centre

Zachary Green iD, Christopher Towriss, James J Ashton, R Mark Beattie, Alison Evans, Amar Wahid, Martin Edwards

Journal of Pediatric Gastroenterology and Nutrition · 2025

DOI: 10.1002/jpn3.70159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Zachary Green und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Acute Child Health, Noah's Ark Children's Hospital for Wales, Cardiff, UK. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Intestines, Colitis, Ulcerative. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Noah's Ark Children's Hospital Charity, Crohn's in Childhood Research Association (CICRA), CICRA research training fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Bowel ultrasound (BUS) is increasingly utilised for monitoring inflammatory bowel disease (IBD), a condition with stringent treatment targets to prevent complications. This study assessed the feasibility of BUS in paediatric IBD and its correlation with established monitoring markers.

Methods

A prospective study was conducted at a specialist paediatric IBD centre, including children aged 2–18 years with IBD diagnosed via modified Porto criteria. BUS parameters were based on paediatric ultrasound scoring systems, with imaging performed by a single paediatric radiologist. Biomarker data (faecal calprotectin, C‐Reactive Protein, Erythrocyte Sedimentation Rate, White Cell Count, Ferritin and Albumin), and paediatric disease activity indices were recorded at time of BUS and again after a median follow‐up of 2.8 months (interquartile range 1.8–4.1). Treatment changes were recorded, and ultrasound findings were correlated with clinical outcomes and inflammatory markers.

Results

Forty patients were included, 27 with ulcerative colitis (UC) or UC‐type IBD‐unclassified. BUS was feasible, with 98% retention ( n = 39) and 96.5% measurable parameters (301/312). Poor‐quality imaging occurred in 10.3%. In UC, bowel wall thickness (BWT, rho = 0.503, p = 0.039) and loss of haustration (rho = 0.490, p = 0.039) correlated with faecal calprotectin; no correlations were found for Crohn's disease or the total cohort. Activity index scores did not correlate with BUS parameters.

Conclusions

BUS shows potential as a noninvasive tool for assessing IBD activity in paediatric patients, especially in colitis where BWT correlates with calprotectin. However, image acquisition challenges highlight the need for expertise. Further studies across diverse cohorts are necessary to establish BUS's utility in paediatric IBD monitoring. Clinical Trial Registration Clinicaltrials.gov (21/12/2022): NCT05673278, https://clinicaltrials.gov/study/NCT05673278 , IRAS ID: 8497/OCT/2022, Date of first enrolment: 01/05/2023.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesIntestinesColitis, UlcerativeHumansChildAdolescentFeasibility StudiesProspective StudiesFemaleMaleUltrasonographyChild, PreschoolBiomarkersLeukocyte L1 Antigen ComplexFecesCrohn DiseaseSeverity of Illness IndexC-Reactive Protein

Stichwörter der Autor:innen

Crohn's diseasechild healthimagingulcerative colitis

Substanzen

BiomarkersLeukocyte L1 Antigen ComplexC-Reactive Protein

Autor:innen und Institutionen

  • Department of Acute Child Health, Noah's Ark Children's Hospital for Wales, Cardiff, UK.
  • Department of Paediatric Gastroenterology, Southampton Children's Hospital, Southampton, UK.
  • Department of Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK.
  • Department of Paediatric Radiology, Noah's Ark Children's Hospital for Wales, Cardiff, UK.
  • Department of Paediatric Gastroenterology, Noah's Ark Children's Hospital for Wales, Cardiff, UK.

ORCID-Profile: Zachary Green

Förderung

  • Noah's Ark Children's Hospital Charity
  • Crohn's in Childhood Research Association (CICRA)
  • CICRA research training fellowship
  • NIHR advanced fellowship

Zitieren

APA

Green, Z., Towriss, C., Ashton, J. J., Beattie, R. M., Evans, A., Wahid, A., & Edwards, M. (2025). Noninvasive monitoring with bowel ultrasound (NIMBUS) in paediatric inflammatory bowel disease: Feasibility in a single centre. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70159

Vancouver

Green Z, Towriss C, Ashton JJ, Beattie RM, Evans A, Wahid A, et al. Noninvasive monitoring with bowel ultrasound (NIMBUS) in paediatric inflammatory bowel disease: Feasibility in a single centre. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.70159

BibTeX
@article{Green2025,
  author = {Green, Zachary and Towriss, Christopher and Ashton, James J and Beattie, R Mark and Evans, Alison and Wahid, Amar and Edwards, Martin},
  title = {Noninvasive monitoring with bowel ultrasound (NIMBUS) in paediatric inflammatory bowel disease: Feasibility in a single centre},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2025},
  doi = {10.1002/jpn3.70159}
}
Kostenlos starten →